Replies to post #304044 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Hate to use buzzwords, but the acquisition was synergistic for NWBO, but is just a very small asset for Corning, which is going through some cost cutting, including a reduction in its R&D outlays,

That simple.

[hyperopia]

I doubt the market is very large for this MicroDEN product right now because, for the most part, the only need for dendritic cells are from clinical trials, with only minimal units required for each. Corning was probably willing to do the deal with Northwest Bio because they will now have a commercial market for their consumables business, and it would eliminate their sales and marketing budget. Well that, and the thought of owning some NWBO stock from the deal probably had them as giddy as schoolgirls. :)

For Corning, I think their deal with Flaskworks may be similar to the printer and ink business model. Flaskworks manufactures the MicroDEN unit, and Corning manufactures all the disposable consumables, and is responsible for sales, marketing, and support. (revenue shared accordingly) When I checked with a distributor last year, the MicoDEN unit was priced at $15k, and all the consumables were ~$800.

“The Corning MicroDEN system is composed of the MicroDEN unit manufactured by Flaskworks, and closed-system consumables manufactured by Corning, such as tissue culture-treated polystyrene flasks, storage bottles, and tubing. The Corning MicroDEN system is jointly branded with Flaskworks and will be marketed, sold, and supported globally by Corning.”

https://www.selectscience.net/product-news/corning-launches-corning-microden-automated-system-for-generating-dendritic-cells/?artID=50630